Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

BUY
$1.27 - $2.26 $13,171 - $23,438
10,371 New
10,371 $15,000
Q4 2021

Jan 07, 2022

SELL
$3.53 - $5.5 $36,426 - $56,754
-10,319 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$4.99 - $6.55 $51,491 - $67,589
10,319 New
10,319 $51,000
Q2 2021

Jul 22, 2021

SELL
$6.24 - $8.22 $50,350 - $66,327
-8,069 Closed
0 $0
Q1 2021

Apr 12, 2021

BUY
$6.74 - $10.95 $2,359 - $3,832
350 Added 4.53%
8,069 $56,000
Q4 2020

Feb 11, 2021

BUY
$3.75 - $10.56 $3,937 - $11,088
1,050 Added 15.74%
7,719 $79,000
Q3 2020

Oct 28, 2020

BUY
$3.5 - $6.2 $525 - $930
150 Added 2.3%
6,669 $23,000
Q2 2020

Jul 20, 2020

BUY
$2.16 - $5.46 $7,560 - $19,110
3,500 Added 115.93%
6,519 $33,000
Q1 2020

Apr 13, 2020

BUY
$1.46 - $7.19 $4,407 - $21,706
3,019 New
3,019 $9,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $231M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.